TG Therapeutics, Inc. TGTX
NASDAQ · United States · Health Technology
$54.09-1.69 (-3.03%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | 0.05 | 0.31 | -83.6% | $240.34M | +4.6% | -6.3%$52.03→$48.74 |
| Q1 2026 | 2026-05-06 | 0.18 | 0.28 | -35.7% | — | — | +19.2% |
| Q4 2025 | 2026-02-26 | 0.14 | 0.33 | -57.6% | — | — | +1.4%$29.66→$30.09 |
| Q3 2025 | 2025-11-03 | 0.16 | 0.22 | -27.3% | — | — | -2.8%$34.78→$33.81 |
| Q2 2025 | 2025-08-04 | 0.17 | 0.29 | -41.4% | — | — | — |
| Q1 2025 | 2025-05-05 | 0.03 | 0.17 | -82.4% | — | — | — |
| Q4 2024 | 2025-03-03 | 0.15 | 0.17 | -11.8% | — | — | — |
| Q3 2024 | 2024-11-04 | 0.02 | 0.03 | -33.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.